JP6356665B2 - 血管閉鎖デバイスおよび方法 - Google Patents
血管閉鎖デバイスおよび方法 Download PDFInfo
- Publication number
- JP6356665B2 JP6356665B2 JP2015516279A JP2015516279A JP6356665B2 JP 6356665 B2 JP6356665 B2 JP 6356665B2 JP 2015516279 A JP2015516279 A JP 2015516279A JP 2015516279 A JP2015516279 A JP 2015516279A JP 6356665 B2 JP6356665 B2 JP 6356665B2
- Authority
- JP
- Japan
- Prior art keywords
- vcd
- support frame
- blood vessel
- closure device
- tether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002792 vascular Effects 0.000 title claims description 85
- 238000000034 method Methods 0.000 title description 47
- 238000007789 sealing Methods 0.000 claims description 242
- 210000004204 blood vessel Anatomy 0.000 claims description 203
- 239000012528 membrane Substances 0.000 claims description 166
- 238000004873 anchoring Methods 0.000 claims description 77
- 239000000463 material Substances 0.000 claims description 74
- -1 polyethylene Polymers 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 229920002530 polyetherether ketone Polymers 0.000 claims description 11
- 239000003356 suture material Substances 0.000 claims description 10
- 230000005012 migration Effects 0.000 claims description 9
- 238000013508 migration Methods 0.000 claims description 9
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 9
- 229920001610 polycaprolactone Polymers 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- 239000004952 Polyamide Substances 0.000 claims description 8
- 239000004698 Polyethylene Substances 0.000 claims description 8
- 239000004642 Polyimide Substances 0.000 claims description 8
- 239000004743 Polypropylene Substances 0.000 claims description 8
- 229920000117 poly(dioxanone) Polymers 0.000 claims description 8
- 229920002647 polyamide Polymers 0.000 claims description 8
- 229920000573 polyethylene Polymers 0.000 claims description 8
- 229920001721 polyimide Polymers 0.000 claims description 8
- 229920001155 polypropylene Polymers 0.000 claims description 8
- 229920000954 Polyglycolide Polymers 0.000 claims description 7
- 229920002313 fluoropolymer Polymers 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 5
- 229920000431 shape-memory polymer Polymers 0.000 claims description 5
- 238000005452 bending Methods 0.000 claims description 3
- RBMHUYBJIYNRLY-UHFFFAOYSA-N 2-[(1-carboxy-1-hydroxyethyl)-hydroxyphosphoryl]-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)(C)P(O)(=O)C(C)(O)C(O)=O RBMHUYBJIYNRLY-UHFFFAOYSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 1
- 229920001434 poly(D-lactide) Polymers 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 238000003780 insertion Methods 0.000 description 55
- 230000037431 insertion Effects 0.000 description 55
- 239000007943 implant Substances 0.000 description 51
- 230000007246 mechanism Effects 0.000 description 39
- 239000003814 drug Substances 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 230000023597 hemostasis Effects 0.000 description 13
- 238000010276 construction Methods 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- 229940124597 therapeutic agent Drugs 0.000 description 11
- 239000003292 glue Substances 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- 230000002093 peripheral effect Effects 0.000 description 10
- 238000003466 welding Methods 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 238000005266 casting Methods 0.000 description 8
- 239000004632 polycaprolactone Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 229910000531 Co alloy Inorganic materials 0.000 description 5
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 5
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 239000007769 metal material Substances 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 238000004026 adhesive bonding Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 229920000249 biocompatible polymer Polymers 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 208000007474 aortic aneurysm Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000003698 laser cutting Methods 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 239000005526 vasoconstrictor agent Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 201000008982 Thoracic Aortic Aneurysm Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000005219 brazing Methods 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010891 electric arc Methods 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 208000003457 familial thoracic 1 aortic aneurysm Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000002330 subarachnoid space Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00597—Implements comprising a membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00654—Type of implements entirely comprised between the two sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00659—Type of implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00668—Type of implements the implement being a tack or a staple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00884—Material properties enhancing wound closure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0417—T-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0641—Surgical staples, i.e. penetrating the tissue having at least three legs as part of one single body
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261658185P | 2012-06-11 | 2012-06-11 | |
| US61/658,185 | 2012-06-11 | ||
| US201261668868P | 2012-07-06 | 2012-07-06 | |
| US61/668,868 | 2012-07-06 | ||
| PCT/US2013/045100 WO2013188351A2 (en) | 2012-06-11 | 2013-06-11 | Vasculature closure devices and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519150A JP2015519150A (ja) | 2015-07-09 |
| JP2015519150A5 JP2015519150A5 (enExample) | 2016-07-14 |
| JP6356665B2 true JP6356665B2 (ja) | 2018-07-11 |
Family
ID=48741511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516279A Expired - Fee Related JP6356665B2 (ja) | 2012-06-11 | 2013-06-11 | 血管閉鎖デバイスおよび方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150094759A1 (enExample) |
| EP (1) | EP2858576A2 (enExample) |
| JP (1) | JP6356665B2 (enExample) |
| CN (1) | CN104394776B (enExample) |
| AU (1) | AU2013274533A1 (enExample) |
| BR (1) | BR112014030858A2 (enExample) |
| CA (1) | CA2873875A1 (enExample) |
| RU (1) | RU2014151209A (enExample) |
| WO (1) | WO2013188351A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2519161B1 (en) | 2009-12-30 | 2020-04-29 | Vivasure Medical Limited | Closure system |
| EP3400879B1 (en) | 2012-02-29 | 2023-09-27 | Vivasure Medical Limited | Percutaneous perforation closure devices |
| WO2015009634A2 (en) | 2013-07-15 | 2015-01-22 | E-Pacing, Inc. | Vasculature closure devices and methods |
| US9861348B2 (en) * | 2014-05-29 | 2018-01-09 | Access Closure, Inc. | Chitosan and polyethylene glycol copolymers and methods and devices for using same for sealing a vascular puncture |
| US11141142B2 (en) | 2014-12-15 | 2021-10-12 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
| EP3232938B1 (en) | 2014-12-15 | 2024-05-01 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
| CN108697414B (zh) | 2015-12-15 | 2022-02-01 | 维瓦舒尔医疗设备有限公司 | 利用带狭槽鞋状物实现有利压力分布的动脉切开术封闭设备 |
| JP6750045B2 (ja) * | 2016-06-10 | 2020-09-02 | テルモ株式会社 | 血管オクルーダー |
| US10448938B2 (en) | 2016-06-16 | 2019-10-22 | Phillips Medical, LLC | Methods and systems for sealing a puncture of a vessel |
| US11045177B2 (en) | 2016-11-02 | 2021-06-29 | Daniel Ezra Walzman | Orientable intracranial occlusion device and method |
| US11638655B2 (en) | 2016-11-02 | 2023-05-02 | Daniel Ezra Walzman | Orientable intracranial occlusion device and method |
| US10624620B2 (en) | 2017-05-12 | 2020-04-21 | Phillips Medical, LLC | Systems and methods for sealing a puncture of a vessel |
| US10716551B2 (en) | 2017-05-12 | 2020-07-21 | Phillips Medical, LLC | Systems and methods for sealing a puncture of a vessel |
| CN109223082B (zh) * | 2018-08-01 | 2020-11-24 | 海南煊烨生物科技有限公司 | 一种用于介入手术的血管支架装置 |
| US12364615B2 (en) | 2019-06-12 | 2025-07-22 | Daniel Ezra Walzman | Orientable intracranial occlusion device and method |
| US12303413B2 (en) | 2019-06-12 | 2025-05-20 | Daniel Ezra Walzman | Orientable implantable device and method |
| CN116322524B (zh) * | 2020-08-31 | 2025-12-09 | 保利埃姆博有限责任公司 | 带有自扩张支柱的封堵装置 |
| US11857172B2 (en) * | 2020-10-29 | 2024-01-02 | Angiomed Gmbh & Co. Medizintechnik Kg | Vascular closure device and method of closing a vascular access hole using such a device |
| WO2022098591A1 (en) * | 2020-11-04 | 2022-05-12 | Walzman Daniel Ezra | Orientable intravascular devices and methods |
| US11944349B2 (en) | 2021-02-25 | 2024-04-02 | Terumo Medical Corporation | Adjustable vascular closure device assembly |
| CN113069153B (zh) * | 2021-05-19 | 2024-07-02 | 资阳市中心医院 | 用于动脉血管上破口的封堵装置 |
| WO2024036049A1 (en) * | 2022-08-11 | 2024-02-15 | Edwards Lifesciences Corporation | Device for controlling pericardial restraint |
| WO2024196425A1 (en) | 2023-03-17 | 2024-09-26 | DRS Vascular, Inc. | Suture retention device |
| CN115969452B (zh) * | 2023-03-21 | 2023-07-18 | 北京普益盛济科技有限公司 | 管腔破口封闭器和管腔破口封闭器输送系统 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
| US6254628B1 (en) * | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
| US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
| DE60327208D1 (de) * | 2002-07-31 | 2009-05-28 | Abbott Lab Vascular Entpr Ltd | Einrichtung zur abschliessung von chirurgischen punktionen |
| US7658748B2 (en) * | 2003-09-23 | 2010-02-09 | Cardia, Inc. | Right retrieval mechanism |
| US9254213B2 (en) * | 2004-01-09 | 2016-02-09 | Rubicon Medical, Inc. | Stent delivery device |
| US20050165427A1 (en) * | 2004-01-22 | 2005-07-28 | Jahns Scott E. | Vessel sealing devices |
| WO2008094706A2 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
| EP2117441A1 (en) * | 2007-02-05 | 2009-11-18 | Boston Scientific Scimed, Inc. | Apparatus and method for closing an opening in a blood vessel using a permanent implant |
| US8568445B2 (en) * | 2007-08-21 | 2013-10-29 | St. Jude Medical Puerto Rico Llc | Extra-vascular sealing device and method |
| US8845682B2 (en) * | 2009-10-13 | 2014-09-30 | E-Pacing, Inc. | Vasculature closure devices and methods |
| WO2011072053A1 (en) * | 2009-12-10 | 2011-06-16 | Neurovasx, Inc. | Aneurysm shield |
| EP3042616A1 (en) * | 2010-02-26 | 2016-07-13 | Promed, Inc. | System and method for vessel access closure |
-
2013
- 2013-06-11 AU AU2013274533A patent/AU2013274533A1/en not_active Abandoned
- 2013-06-11 BR BR112014030858A patent/BR112014030858A2/pt not_active IP Right Cessation
- 2013-06-11 EP EP13733139.3A patent/EP2858576A2/en not_active Withdrawn
- 2013-06-11 CN CN201380032941.7A patent/CN104394776B/zh not_active Expired - Fee Related
- 2013-06-11 CA CA2873875A patent/CA2873875A1/en not_active Abandoned
- 2013-06-11 RU RU2014151209A patent/RU2014151209A/ru not_active Application Discontinuation
- 2013-06-11 WO PCT/US2013/045100 patent/WO2013188351A2/en not_active Ceased
- 2013-06-11 JP JP2015516279A patent/JP6356665B2/ja not_active Expired - Fee Related
-
2014
- 2014-12-11 US US14/566,805 patent/US20150094759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015519150A (ja) | 2015-07-09 |
| US20150094759A1 (en) | 2015-04-02 |
| CA2873875A1 (en) | 2013-12-19 |
| CN104394776A (zh) | 2015-03-04 |
| CN104394776B (zh) | 2017-12-08 |
| AU2013274533A1 (en) | 2014-12-04 |
| BR112014030858A2 (pt) | 2017-06-27 |
| EP2858576A2 (en) | 2015-04-15 |
| WO2013188351A3 (en) | 2014-04-03 |
| RU2014151209A (ru) | 2016-08-10 |
| WO2013188351A2 (en) | 2013-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6356665B2 (ja) | 血管閉鎖デバイスおよび方法 | |
| US20220218323A1 (en) | Closure system and uses thereof | |
| RU2553939C2 (ru) | Устройство, способ и система для закрытия сосуда | |
| KR101426627B1 (ko) | 조직 봉합 장치, 이송용 장치 및 시스템, 키트 및 이를 위한 방법 | |
| US10918391B2 (en) | Method and apparatus for clamping tissue and occluding tubular body lumens | |
| EP2663244B1 (en) | Apparatus for securing tissue layers together | |
| CN102458264B (zh) | 组织封闭装置、输送装置和系统、用于其的套件和方法 | |
| US20200038003A1 (en) | Devices and methods for occluding or promoting fluid flow | |
| US9060751B2 (en) | Surgical closure systems and methods | |
| US20140081318A1 (en) | Tissue closure devices, device and systems for delivery, kits and methods therefor | |
| US20110144661A1 (en) | Tissue closure devices, device and systems for delivery, kits and methods therefor | |
| US20170095257A1 (en) | Devices and methods for occluding an atrial appendage | |
| CN112022260B (zh) | 一种具有仿生微刺依附结构的植入器械 | |
| EP3021762B1 (en) | Vasculature closure devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160525 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160525 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170301 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170303 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170515 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170920 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171219 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180524 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180614 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6356665 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |